Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Neuroimage|August 26, 2009
FDDNP binding using MR derived cortical surface mapsH D Protas, S-C Huang, V Kepe, et al.
International Journal of Geriatric Psychiatry|March 3, 2012
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imagingL M Ercoli, G W Small, P Siddarth, et al.
Science (New York, N.Y.)|August 13, 1993
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset familiesE H Corder, A M Saunders, W J Strittmatter, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|March 10, 2001
Cognitive and metabolic responses to metrifonate therapy in Alzheimer diseaseM S Mega, J L Cummings, S M O'Connor, et al.
JAMA|March 22, 1995
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer diseaseG W Small, J C Mazziotta, M T Collins, et al.
Annals of the New York Academy of Sciences|December 16, 1996
Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimagingG W Small, S Komo, A La Rue, et al.
Neurology|January 27, 1998
Sulcal variability in the Alzheimer's brain: correlations with cognitionM S Mega, P M Thompson, J L Cummings, et al.
International Journal of Alzheimer'S Disease|May 12, 2011
Thickness in entorhinal and subicular cortex predicts episodic memory decline in mild cognitive impairmentA C Burggren, B Renner, M Jones, et al.
Neurogenetics|December 14, 1999
No association between the HLA-A2 allele and Alzheimer diseaseG W Small, W K Scott, S Komo, et al.
Neuroscience Letters|May 10, 1996
No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American CaucasiansM L Pritchard, A M Saunders, P C Gaskell, et al.
Pageof 14